[1] 中华人民共和国卫生部. 2000年全国结核病流行病学抽样调查资料汇编[M]. 北京:人民卫生出版社, 2003.
[2] 世界卫生组织. 耐药结核病规划管理指南[M].WHO/HTM/TB/2006:361.
[3] Takiff HE, Salazar L, Guerrero C, Philipp W, Huang WM, Kreiswirth B, Cole ST, Jacobs WR Jr, Telenti A.Cloning and Nucleotide Sequence of Mycobacterium tuberculosis gyrA and gyrB and Detection of Quinolone Resistance Mutations[J].Antimicrob Agents Chemother,1994,38(4):773-780.
[4] 萨姆布鲁克. 分子克隆实验指导(第二版)[M].北京:科学出版社,1998:955.
[5] Rodríguez JC, Cebrián L, López M, Royo G. Mutant prevention concentration: comparison of fluoquinolones and linezolid with Mycobacterium tuberculosis[J]. J Antimicrob Chemother,2004, 53(2):441-444.
[6] Guillemin I, Cambau E, Jarlier V. Sequences of Conserved Region in the A Subunit of DNA Gyrase from Nine Species of the genus Mycobacterium: phylogenetic analysis and implication for intrinsic susceptibility to quinolones[J]. Antimicrob Agents Chemother,1995,39(9):2145-2149.
[7] Ginsburg AS, Sun R, Calamita H, Scott CP, Bishai WR, Grosset JH. Emergence of fluoroquinolone resistance in Mycobacterium tuberculosis during continuously dosed moxifloxacin monotherapy in a mouse model[J]. Antimicrob Agents Chemother, 2005,49(9):3977-3979.
[8] Onodera Y, Tanaka M, Sato K. Inhibitory activity of quinolones against DNA gyrase of Mycobacterium tuberculosis[J]. J Antimicrob Chemother, 2001,47(4):447-450.
[9] Kam KM, Yip CW, Cheung TL, Tang HS, Leung OC, Chan MY. Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility[J]. Microb Drug Resist, 2006,12(1):7-11.
[10] Cheng AF, Yew WW, Chan EW, Chin ML, Hui MM, Chan RC. Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates[J]. Antimicrob Agents Chemother, 2004,48(2):596-601.
[11] Sulochana S, Narayanan S, Paramasivan CN, Suganthi C, Narayanan PR. Analysis of fluoroquinolone resistant in clinical isolates of Mycobacterium tuberculosis from India[J]. J Chemother,2007,19(2):166-171.
[12] Sun Z, Zhang J, Zhang X, Wang S, Zhang Y, Li C. Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates[J]. Int J Antimicrob Agents,2008,31(2):115-121.
[13] 安慧茹,王巍,王天昊,何珂,刘真,李素梅. 结核分枝杆菌喹诺酮耐药基因的研究[J].医学临床研究,2005,22(1):23-29.
[14] 赵明才,鲍朗,吴悦涵,龙洋,曾献武,张会东,谢益新. 四川地区结核分枝杆菌喹诺酮耐药基因突变研究[J].四川大学学报,2004,35(3):313-315.
|